Cagrilintide 10mg — Vial Spec, Reconstitution Math & COA

Overview of Cagrilintide 10mg Vial Specifications

Cagrilintide is a long-acting, acylated non-selective amylin and calcitonin receptor agonist (DACRA) designed to mimic endogenous amylin function while exhibiting enhanced pharmacokinetic stability. In laboratory settings, the 10mg lyophilized vial format serves as a high-density primary standard or working supply for researchers executing high-throughput screening, receptor binding assays, or multi-week rodent metabolic trials. Supplying this compound in a 10mg mass reduces lot-to-lot variable exposure across extended experimentation timelines.

The lyophilized cake inside each 10mg vial contains high-purity cagrilintide peptide combined with minimal bulking agents to preserve bioactivity during vacuum-drying and cold storage. When evaluating laboratory requirements, investigators can explore the full catalog at /all-peptides or review specific cagrilintide mass options directly on the dedicated /product/cagrilintide product page. If a specific 10mg fill mass is currently out of stock or custom-ordered, PX1 Research provides equivalent research-grade mass alternatives and continuous inventory updates for institutional buyers.

Mechanistic Profile and Research Context

Cagrilintide functions as a acylated lipophilic peptide analog that binds with high affinity to human amylin receptors (AMY1, AMY2, and AMY3) as well as the calcitonin receptor (CTR). In preclinical metabolic models, activation of these neuroendocrine receptor pathways in the area postrema and nucleus of the solitary tract leads to modulated gastric emptying kinetics, central satiety signal transduction, and alterations in energy expenditure parameters.

Unlike native amylin, which suffers from rapid enzymatic clearance and a propensity to form insoluble amyloid fibrils, cagrilintide features structural modifications—specifically amino acid substitutions and a fatty acid side chain—that facilitate non-covalent binding to albumin. This structural design extends the plasma half-life in animal models, making it an advantageous compound for investigating multi-day metabolic cascades without requiring continuous infusion equipment.

Reconstitution Math and Volumetric Concentrations

Accurate reconstitution math is critical when preparing a 10mg cagrilintide vial for experimental work. Because 10mg (10,000 micrograms) represents a substantial peptide mass, selecting the correct diluent volume directly dictates the final working concentration (mg/mL or µg/µL) and determines pipetting accuracy for micro-liter assays.

To achieve a targeted working concentration using common laboratory diluents (such as Bacteriostatic Water with 0.9% benzyl alcohol or Sterile Water for Injection), apply the following volumetric ratios: • 1.0 mL Diluent Addition: Yields a concentration of 10.0 mg/mL (10.0 µg/µL). This high-density ratio is optimal for low-volume micro-aliquoting or stock storage. • 2.0 mL Diluent Addition: Yields a concentration of 5.0 mg/mL (5.0 µg/µL). This balanced concentration simplifies pipette measurement for standard microcentrifuge work. • 3.0 mL Diluent Addition: Yields a concentration of 3.33 mg/mL (3.33 µg/µL). This lower density is advantageous when preparing working dilutions for cellular assays requiring reduced localized osmotic stress.

To quickly recalculate custom diluent volumes or verify micro-gram dosages across varied vial sizes, researchers should utilize the interactive /reconstitution-calculator tool before beginning liquid handling procedures.

Aliquot Planning and Long-Term Stability Protocols

Managing a 10mg peptide mass requires an explicit aliquot protocol to protect structural integrity. Repeated freeze-thaw cycles subject peptide chains to physical shear forces and localized ice crystal formation, which can cause aggregation, precipitation, or secondary structure denaturing.

Upon full reconstitution, the stock solution should be immediately divided into single-use or weekly-use polypropylene microcentrifuge tubes under sterile laminar flow conditions. Lyophilized vials stored at -20°C or -80°C remain stable through their expiration date. Once reconstituted in bacteriostatic diluent, working aliquots stored at 2°C to 8°C maintain functional stability for up to 28 days. Unused frozen aliquots kept at -80°C avoid repeated thermal fluctuations, safeguarding assay reproducibility across extended multi-month study protocols.

Quality Control, Purity, and Lot-Matched COAs

Quality control verification is paramount for institutional non-clinical research. Every batch of cagrilintide produced for PX1 Research undergoes strict analytical evaluation in an ISO 17025 accredited laboratory to verify structural identity, peptide purity, and freedom from biological contaminants.

Purity is assessed via High-Performance Liquid Chromatography (HPLC), ensuring target peptide purity consistently meets or exceeds 99.0%. Mass identity is verified using Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm exact molecular weight against theoretical values. Furthermore, Bacterial Endotoxin testing via the Limulus Amebocyte Lysate (LAL) assay guarantees endotoxin levels remain under strict threshold limits (<0.01 EU/mg), eliminating confounding inflammatory variables in cell culture or animal models. Laboratory managers can independently inspect and download lot-matched documentation at the /coa repository.

Comparative Analysis: Cagrilintide vs. Related Metabolic Peptides

When designing comparative metabolic research trials, investigators frequently contrast cagrilintide against established metabolic research peptides. The primary distinction lies in receptor selectivity and cellular signaling pathways: while incretin mimetics act on metabolic receptors, cagrilintide specifically targets the amylin and calcitonin receptor families.

For example, researchers exploring incretin-based metabolic regulation often compare or co-administer cagrilintide alongside GLP-1 and GIP receptor agonists such as semaglutide or dual/triple agonists like tirzepatide and retatrutide. In contrast to early-generation amylin analogs like pramlintide, cagrilintide offers significantly enhanced lipophilic acylation, extending its half-life and eliminating the need for short-interval dosing in longitudinal rodent models. Investigating these distinct pathways helps researchers elucidate additive or synergistic physiological mechanisms in energetic homeostasis.

Selecting the Optimal Fill Mass: 2mg vs 5mg vs 10mg

Determining whether a 10mg vial or a smaller mass configuration best suits a laboratory project depends on experimental scale, throughput requirements, and reconstitution timelines. Utilizing a 10mg vial provides maximum cost efficiency and reduced batch variance for high-volume, multi-subject rodent trials or continuous automated assay platforms.

Conversely, pilot studies, short-duration cellular experiments, or exploratory assays may benefit from smaller mass options, such as 2mg or 5mg vials, to minimize peptide loss associated with discard dates of reconstituted liquid stocks. Research facilities seeking high-volume bulk supply or custom lyophilization runs across variable unit sizes can submit requirements through the /wholesale portal, or review standard catalog availability in the general /research directory.

Laboratory Handling, Reconstitution Technique, and Safety

Proper aseptic technique is required when handling lyophilized research peptides. Reconstitution must take place inside a certified biosafety cabinet or clean bench environment. Before inserting a syringe needle, the rubber stopper of the vial should be disinfected using a 70% isopropyl alcohol wipe and allowed to air dry completely.

When introducing the diluent, target the liquid stream against the inner glass wall of the vial rather than shooting it directly onto the lyophilized cake. Allow the diluent to gently saturate the powder, then gently swirl the vial until dissolved. Never shake or vortex cagrilintide solutions, as mechanical agitation causes surface-tension cavitation that disrupts peptide conformation. All waste materials, including single-use syringes and empty vials, must be disposed of in accordance with institutional biosafety standards.

PX1 Research Supply Chain and Quality Guarantee

PX1 Research synthesizes and packages research-grade peptides within state-of-the-art, USA-based GMP-compliant manufacturing facilities. Operating out of primary distribution centers in California and Arizona, PX1 ensures expedited transit times, offering same-day dispatch for orders confirmed Monday through Friday before cut-off thresholds.

By enforcing strict cold-chain logistics, rigorous HPLC/MS identity testing, and lot-specific transparency, PX1 Research provides institutional laboratories with dependable access to uncompromised research compounds. Every peptide mass—from micro-gram analytical samples to 10mg primary production lots—is maintained under strict temperature-controlled storage prior to shipment.